Director of Patient & Clinical Research Programmes at the Follicular Lymphoma Foundation; board member @elly_charity; trustee at Age UK. Tweets my own.
The 2025 Global Follicular Lymphoma Patient Survey is live.
Too often, decisions are made without hearing from patients. This survey changes that.
✔ Anonymous ✔ English & Spanish ✔ 5–10 mins
Help shape the future of FL care: https://t.co/pQ4ZPsVqsB
Delighted to be at #ASH24 representing FLF’s commitment to putting patients at the heart of what we do. Over the next few days, we’ll amplify voices of those with follicular lymphoma, ensuring their perspectives guide research and treatment advances. Follow @Cure_FL for updates.
Are you a Follicular Lymphoma patient, partner, caregiver, or physician? Your insights matter! Help shape patient-centered care by taking our survey. Open to FL patients, partners & caregivers in the US, UK, Spain, Australia, & Canada. Survey closes soon! https://t.co/N8Q3ORoF8V
📢Join our session on emerging FL treatments, covering CAR-T therapy, bispecific antibodies, and more! Hear a patient’s journey and connect with experts on the latest in FL care.
🗓️Date: Nov 25, 2024
⏰Time: 9:30 - 10:30 | 14:30 - 15:30
🔗Register now! https://t.co/kkkPWxmIyV
Listen to Dr Mitchell Smith, FLF’s Chief Medical Officer, as he highlights the importance of your voice.
📢 Your opinion matters! 📢
Help shape the future of FL care and improve treatment decisions for FL patients! Click the link in our bio to fill out our latest survey.
Thrilled to join @bloodcancer_uk & The Joyce and Norman Freed Charitable Trust in funding a world-class study led by Dr. Kim Linton at The Christie in Manchester, UK. This research will advance how we treat #FollicularLymphoma🧬🩺
Thank you for supporting this vital work 💜
Proud to have been a part of this important study - Time-lapse imaging does not improve the odds of live birth in women having IVF and ICSI treatments.
Published in @TheLancet , this randomized controlled trial (RCT) explores the role of time-lapse imaging (TLI) in in vitro fertilization (IVF). The results are quite revealing: TLI doesn’t actually improve the success rates of IVF treatments.💉🔬
👉🏻 https://t.co/qcVJW0sBlI
Hear Nicky's inspiring clinical trial story and insights from top experts at our clinical trials webinar and empower your patient journey!
23 July 24 | 13:00 BST | 8:00 EDT | 20:00 AWST
🎥 FREE event! Register and submit your questions: https://t.co/bH16bzFbnw
Dr. Julie Dodds & Dr. Mitchell Smith are leading a workshop for the CURE FL Investigators at the Advances in Malignant Lymphoma conference in Philadelphia, advancing research to cure FL. @AACR, @icmlugano, @BCD_AACR, #AACRlymph24.
We had an amazing time at the EHA conference in Madrid!
We're excited to expand our European collaborations, strengthen partnerships, and share our learnings around FL research.
Stay tuned for more!
#EHA2024#FollicularLymphoma
Excited to be attending my first European Hematology Association conference! Looking forward to reconnecting with colleagues, making new connections, whilst shining a spotlight on Follicular Lymphoma in Europe. #EHA2024#Hematology#FollicularLymphoma@Cure_FL
The FLF survey is live. If you are living with follicular lymphoma please take a moment to complete this important survey. Every voice matters. Thank you.
https://t.co/1BPMVY18WY
The FLF patient survey on immunotherapy is LIVE!
📢 Your voice matters! Please take a few minutes to participate in our short survey and share your thoughts.
Click the link to get started: https://t.co/aFdE2IPFa0
Live for 2 weeks only!
FLF, @llsusa & iFLi co-hosted a workshop in the US bringing together global FL experts who share the vision that an FL bio data bank is key to advancing the field. We participated in a FL ‘Roadmap to a Cure’ workshop about critical knowledge gaps essential for finding a cure.
We need better biomarkers for FL, to transform patient outcomes. Partnered with the Mark Foundation for Cancer Research to tackle this need together. At #ASH2023, we co-hosted a workshop with investigators, with a goal to establish a collaborative grant programme focused on this.
Biomarkers are a naturally occurring characteristic in which a specific disease can be identified. The FL Biomarker Discovery programme is important to help with our mission. Fill out our short poll 💜
English link: https://t.co/roRcsRF4nA
Spanish link: https://t.co/wj397GKhkC
We are excited to announce the success of our collaborative initiative with @LLSusa - the "LLS-FLF Research United to CURE FL Awards." We have received numerous proposals from internationally recognised experts from around the globe! 🌍
Read more here: https://t.co/GHI4iQX69L